JNJ vs HCA
By Alex · Tickerpine
Johnson & Johnson vs HCA Healthcare, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | HCA |
|---|---|---|
| Price | $285.75 | $499.05 |
| Market cap | $687.89B | $104.25B |
| P/E ratio | 43.4 | 16.6 |
| ROE | 20.02% | — |
| Profit margin | 16.20% | 8.61% |
| Revenue growth | 5.90% | 3.60% |
| Dividend yield | 1.88% | 0.63% |
| Beta | 0.20 | 1.10 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs HCA in plain English
- JNJ is the bigger company — about 6.6× the market cap of HCA.
- HCA is cheaper on earnings (P/E 16.6 vs 43.4).
- JNJ is growing revenue faster (6% vs 4%).
- JNJ has the higher dividend yield (1.88% vs 0.63%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
HCA return calculator
See what $1,000 in HCA Healthcare, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.